Friday, February 3, 2017

*Subject to change
Sessions indicating a badge color are limited to the respective covered entity, industry or government groups. Learn more about badge colors. Badge colors



Charity Fun-Run & Walk (check-in will begin at 6:30am)
Location: Grand Ballroom Foyer


Continental Breakfast and Stakeholder Networking Opportunity
Location: Pacific Concourse


Ask the Experts for Pharmaceutical Manufacturers (manufacturers only)
Badge Color: Pharmaceutical Manufacturers
Marina Room

This session is an opportunity for pharmaceutical manufacturers to hear from an expert who works on a broad range of 340B-related issues.  A consultant with significant experience with 340B and other federal drug pricing programs will field your questions in this small group discussion.

Marcy Imada, Principal, Deloitte & Touche LLP (Facilitator)


Legislative Update
Location: Grand Ballroom 

With a new Congress and Administration, changes to our health care system remain a key priority in 2017. Attendees will be briefed about what to expect from Washington and hot-button pharmaceutical and biotech industry issues. Attendees will also hear the perspectives of safety-net providers on key developments in the 340B area as well as learn about new leaders in key positions in the Trump Administration and in Congress and how they will play a key role in shaping health care policy going forward.

Mike McCaughan, Senior Editor, The RPM Report/Prevision Policy
Ellen Riker, Senior Vice President, Cavarocchi, Ruscio, Dennis Associates; Counsel to Hemophilia Alliance
Rodney WhitlockVice President, Health Policy ML Strategies, LLC
Kathryn DiBitetto, Director, Government Relations, 340B Health, (Moderator)



Exhibitor Forum, Refreshment Break, Networking Opportunity
Location: Pacific Concourse


Track One - 340B Operations

Inventory Management: Strategies for Compliance and Efficiency
Location: Grand Ballroom A

340B providers must develop inventory management systems that are compliant with 340B program rules, including patient definition and the duplicate discount prohibition.  Developing such systems can be especially challenging if a covered entity uses a contract pharmacy, which typically serves a large number of patients ineligible to receive 340B drugs.  Many hospitals face the additional challenge of ensuring compliance with the group purchasing organization exclusion, which usually requires the hospital to set up and incorporate wholesale acquisition cost (WAC) purchasing accounts into their systems.  During this session, speakers will describe inventory management systems in both the HRSA grantee and hospital settings and will share the lessons they have learned related to inventory management.

Chad Johnson, 340B Program Manager, Froedtert Health
Mark Malahosky, Vice President, Pharmacy Services, Trillium Health
Jeff Thompson, Vice President of Pharmacy Services, Freeman Health System
Steven Miller, Pharmacy Services Director, 340B Health (Moderator)


Track Two - 340B Policy and Compliance

Preparing for HRSA Audits, Taking Corrective Action and Responding to Manufacturer Inquiries
Location: Grand Ballroom BC

Program integrity is a critical requirement for 340B covered entities.  HRSA audits covered entities to ensure their compliance with 340B program requirements and expects covered entities to monitor their compliance status through internal self-audits.  Given the complex and evolving nature of 340B, covered entities may still experience compliance issues despite making sincere efforts to enhance 340B program integrity.  What if a compliance problem is detected by HRSA or by your organization through an internal self-audit?  What kind of corrective action will be needed?  Providers who have been audited by HRSA will address these questions and will review the audit process so that your entity can feel prepared when it receives an audit notice from HRSA.  This session will also review the audit authority of 340B manufacturers and how covered entities should respond to manufacturer communications that inquire into their 340B drug use.

Purnank Gandhi, Pharmacy Manager, Medical Associates Plus
Jessica Moser, Pharmacy Specialist, 340B, Dignity Health
Bill von Oehsen, Principal, Powers Pyles Sutter & Verville, PC (Moderator)


Track Three - Clinical Best Practices

Transforming the Delivery System to Improve Patient Care: Pharmacy as a Critical Tool
Location: Seacliff CD

Representatives from covered entities will describe how delivery system innovation such as consolidation, focus on "systemness" and using teams applied to the practice of pharmacy can improve patient outcomes and better manage the cost of care.

Carla DeSilva-Carver, Outcomes Manager, Population Health, CoxHealth
Lisa Nelson, Pharmacy Manager, Unity Care Northwest
Russell Smith, Vice President, Clinical Services, University of Toledo
Donald Davies, Pharmacy Government Programs Coordinator, Indiana University Health (Moderator)


Small Group Discussions/Roundtables

A) Rural Provider Roundtable
Location: Garden A

Rural safety net providers in the 340B program face their own set of challenges that are unique to their geographic settings and the populations they treat.   Their remote location and limited resources can require a different approach to 340B and how to meet the needs of their patient populations.  In particular, unlike other hospitals in 340B, rural hospitals are subject to the orphan drug exclusion and access discounted drug pricing in different ways than other 340B providers.  This informal session will offer rural providers the opportunity to network with other rural providers that may face similar challenges.  Facilitators will be present to lead small group discussions and allow rural health care providers to share their experiences managing 340B programs and working to meet the needs of vulnerable, rural populations.

Gretchen Beckham, Director of Pharmacy, Eau Claire Cooperative Health Center
Jeff Davis, Legislative and Policy Counsel, 340B Health
Kevin Jones, 340B Drug Pricing Program Director, Intermountain Healthcare
Dominic Mellette, Director of Pharmacy, Carolina Health Centers
Vinny Polito, Pharmacy Manager, Centura Health, Avista Adventist Hospital
Sam Wilhelm-Ross, Regulatory Policy Manager, 340B Health (Facilitator)

B) CHC Expert: Changes and Challenges in Reimbursement for Health Center 340B Pharmacies
 Badge Color: Community Health Centers
Location: Seacliff AB

This session will provide an overview of changes in Medicaid reimbursement and contract pricing models that are resulting in shrinking margins for health center 340B pharmacies.  A panel of experts will discuss:

  • Strategies for striking a favorable balance with state Medicaid (including state specific examples);
  • What the health center can (and should) do in the face of “predatory” contract proposals; and
  • Operational strategies for remaining viable in the face of shrinking margins.

Michael Glomb, Partner, Feldesman Tucker Leifer Fidell LLP; Counsel, National Association of Community Health Centers
Judy Lapinski, Chief Operating Officer,  Mid-Atlantic Association of Community Health Centers
Colleen Meiman, Director of Regulatory Affairs, National Association of Community Health Centers
Kenneth Pacheco, Program Manager 340B and Lab, Access Community Health
Sue Veer, President and Chief Executive Office, Carolina Health Centers (Moderator)


Passport and Social Media Contest Prize Drawings & Closing Remarks
Location: Grand Ballroom BC


Conference Adjourns

Featured Sponsors